Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
PARACENTESIS KIT, REF: AK-00376, ASK-00376-VCU
REF(Material)/UDI-DI/Lot(Batch): AK-00376/10801902197938, 10801902193275, 10801902197938, 10801902197952/33F24D0004, 33F24E0166, 33F24G0318, 33F24J0486, 33F24K0083, 33F24L0725, 33F25A0453, 33F25A0610, 33F25C0749, 33F25C0906, 33F25E0031, 33F25G0075, 33F25H0007, 33F25H0719, 33F25J0739, 33F25J0817, 33F25L0462, 33F25M0954, 33F26B0949, 33F26C0575, 33F24A0016; ASK-00376-VCU/10801902193275, 10801902138788/33F24L0522, 33F24M0088, 33F25C0060, 33F25D0282, 33F25F0257, 33F25G0746, 33F25J0602, 33F24D0201
Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.